Press Releases

Date Title and Summary Additional Formats
Toggle Summary Quotient Limited to Report Second Quarter Fiscal 2017 Financial Results and Host Conference Call
JERSEY, Channel Islands, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Quotient Limited  (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal second quarter ending September 30, 2016 will be released after market close on Monday, October 31, 2016.
View HTML
Toggle Summary Quotient Limited Announces $120 Million Secured Debt Financing
JERSEY, Channel Islands, Oct. 14, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (" Quotient ") (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the completion of a private placement of up to $120 million of 12% Senior Secured Notes due 2023.
View HTML
Toggle Summary Quotient Limited Announces Successful Validation of the Initial Manufacturing System for MosaiQ™ Microarrays
MosaiQ TM manufacturing system operating in accordance with design requirements Ongoing evaluation of MosaiQ TM methodology continues to demonstrate concordance levels in excess of 99.0% for key blood group antigen specificities JERSEY, Channel Islands, Sept.
View HTML
Toggle Summary Quotient Limited Reports Further Progress on the Commercial Scale-up of MosaiQ™ and First Quarter Fiscal 2017 Financial Results
Facility modification completed — humidity control successfully resolved issue previously impacting final assembly of MosaiQ™ consumables Validation of the initial manufacturing system for MosaiQ™ consumables planned for completion by the end of August 2016 Instruments
View HTML
Toggle Summary Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares
JERSEY, Channel Islands, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the closing of its underwritten public offering of 3,220,000 of its ordinary shares at a price to the public of $5.50 per share, which includes the
View HTML
Toggle Summary Quotient Limited to Report First Quarter Fiscal 2017 Financial Results and Host Conference Call
JERSEY, Channel Islands, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Quotient Limited  (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first quarter ending June 30, 2016 will be released after market close on Monday, August 8 th , 2016.
View HTML
Toggle Summary Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares
JERSEY, Channel Islands, July 29, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the pricing of an underwritten public offering of 2,800,000 of its ordinary shares at a price to the public of $5.50 per share.
View HTML
Toggle Summary Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares
JERSEY, Channel Islands, July 28, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it intends to commence an underwritten public offering of its ordinary shares. Jefferies LLC is acting as sole bookrunner for the offering.
View HTML
Toggle Summary Quotient Limited Provides Update on the MosaiQ™ Development Plan and Reports Preliminary Fiscal First Quarter 2017 Revenues
Manufacturing system for MosaiQ™ consumables meeting design expectations Field trial instruments successfully pass rigorous internal evaluation Minor manufacturing facility modification recently identified and underway; expected commencement of European field trials to be delayed by six to
View HTML
Toggle Summary Quotient Limited to Participate in Jefferies 2016 Global Healthcare Conference
JERSEY, Channel Islands, May 31, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the company's Chairman & CEO, Paul Cowan, will present at the Jefferies 2016 Global Healthcare Conference in New York City at 2:00 p.m.
View HTML